ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Stephen · 0 0

Patient Basic Information Patient: Mr. Stephen (Stephen Rodriguez) Nationality: Algeria Disease Diagnosis: Lymphoma Diagnostic Hospital: H0H treatment: Targeted Treatment + Immunotherapy Accommodation: 159 days Treatment cost: about 138,494 yuan Treatment effect: Functional recovery The patient is from Algeria and was diagnosed with Lymphoma locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process.

The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process. After 159 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results: Patient's final functional recovery.

At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track the recovery through a remote follow-up system. 'Mr. Stephen has criticized this case as a typical case of cross-border suspected seriousness clinical disease.

The multi-disciplinary collaborative mechanism for developing targeted therapeutic+immunotherapies for lymphoma reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and is a shorthand for the regulation of international visitor medical services.

阿尔及利亚,淋巴瘤,中山大学附属第一医院,国际医疗,来华就医,中国医疗